Validation of Ultrasound "Angle of Progression" Measurement to Decrease the Cesarean Rate
DELIVERY
1 other identifier
interventional
182
1 country
7
Brief Summary
Ultrasound during labor and measurement of Angle of progression showed extensive prospective and retrospective publications since 2010. The investigators performed between 2013 and 2016 the only one multicenter, randomized controlled Trial comparing digital exam to angle of progression after a prolonged 2-hour second stage of labor with uncertain fetal head. The investigators consider a cut off of 120° to accepted vaginal birth among cephalic occiput anterior position This randomised PILOT study showed that measurement of Angle of progression in addition to digital exam reduced caesarean delivery from 41% to12% ( n= 33, p=0,06). doi: 10.1016/j.ajog.2022.04.018. The objective of this new study is therefore to validate the results of this PILOT study in a more powerful multicenter randomized trial (DELIVERY).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2023
Typical duration for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2023
CompletedFirst Posted
Study publicly available on registry
March 22, 2023
CompletedStudy Start
First participant enrolled
September 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 13, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 13, 2025
CompletedFebruary 15, 2024
February 1, 2024
2 years
March 9, 2023
February 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
cesarean delivery rate
Demonstrate that the angle of progression measurement would change by 20% the cesarean rate after a prolonged second stage of labor (2 hours).
baseline
Secondary Outcomes (5)
Number of complicated deliveries in each group
baseline
Severe maternal morbidity, in each group
1 month
Severe neonatal morbidity, in each group
1 month
Rate of admission to neonatal intensive care unit, in each group
1 month
Concordance rate between the routinely AOP measurement and the centralized AOP measurement reading
1 month
Study Arms (2)
Group 1 : control
NO INTERVENTIONThe mode of delivery will be determined by clinical examens (digital examination)
Group 2 : Transperineal ultrasound measurements of AOP
EXPERIMENTALThe mode of delivery will be determined by clinical examens (digital examination) and ultrasound measurement of the AOP : * vaginal delivery is encouraged if AOP measurement is \>120° * cesarean delivery is encouraged if AOP measurement is \<= 120°
Interventions
The angle of progression (AOP) defined as the angle between the pubic bone axis and the leading part of the fetal head
Eligibility Criteria
You may qualify if:
- Nulliparous or multiparous women with no history of vaginal delivery,
- \> or = 37 weeks amenorrhoea
- Cephalic presentation in anterior position (occipito-pubic position, left anterior occipito-iliac and right anterior occipito-iliac ) confirmed by ultrasound
- uncertain fetal head engagement on digital examination or midline fetal presentation in prolonged second stage of labor (at least 2 hours),
You may not qualify if:
- Multiparous women who were previous vaginal deliveries,
- Presentation other than cephalic,
- Twin pregnancies,
- Posterior or transverse position
- Transperineal ultrasound for head-perineum distance measurement
- Fetal heart rate abnormalities requiring rapid delivery,
- Contraindication to vaginal delivery whether maternal or fetal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
CHU de Lille - Hôpital Jeanne de Flandre
Lille, 59000, France
APHM Hôpital Conception
Marseille, 13005, France
Hopital Saint Joseph
Marseille, 13008, France
APHM Hôpital Nord
Marseille, 13015, France
Hôpital Armand Trousseau AP-HP
Paris, 75012, France
CHIC Poissy
Poissy, 78300, France
CHITS Hôpital Sainte Musse
Toulon, 83000, France
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Baptiste Haumonte
Hopital Saint Joseph Marseille
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 9, 2023
First Posted
March 22, 2023
Study Start
September 13, 2023
Primary Completion
September 13, 2025
Study Completion
October 13, 2025
Last Updated
February 15, 2024
Record last verified: 2024-02